R. Michael Carruthers, Chief Financial Officer at Edgewise Therapeutics, Inc. (EWTX), sold 1,428 shares at $13.39 ($19K) on 2025-08-12, disclosed to the SEC on 2025-08-14.
Open-market sale of $19k EWTX by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| EWTX | SELL | 2024-05-03 | $41K | — | Filing → |
| EWTX | SELL | 2024-01-25 | $1.4M | — | Filing → |
| EWTX | SELL | 2023-05-03 | $12K | — | Filing → |